Chemical Compound

1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4,9-dihydroxy-, (4S)-; 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4,9-dihydroxy-, (S)-; Camptothecine, 10-hydroxy- (8CI); (+)-10-Hydroxycamptothecin; (S)-10-Hydroxycamptothecin; 10-Hydroxycamptothecin; 10-Hydroxycamptothecine; ChEMBL 273862; Hydroxycamptothecin; NSC 107124; (S)-4-ethyl-4,9-dihydroxy-1H-pyrano[3'4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; Topotecan related; SKF-S-104961; Irinotecan Related Compound A; Irinotecan Hydrochloride Trihydrate Impurity B; Irinotecan Impurity B

CAS Registry Number 19685-09-7
返回搜索 申请报价
1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4,9-dihydroxy-, (4S)-; 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4,9-dihydroxy-, (S)-; Camptothecine, 10-hydroxy- (8CI); (+)-10-Hydroxycamptothecin; (S)-10-Hydroxycamptothecin; 10-Hydroxycamptothecin; 10-Hydroxycamptothecine; ChEMBL 273862; Hydroxycamptothecin; NSC 107124; (S)-4-ethyl-4,9-dihydroxy-1H-pyrano[3'4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; Topotecan related; SKF-S-104961; Irinotecan Related Compound A; Irinotecan Hydrochloride Trihydrate Impurity B; Irinotecan Impurity B 结构式
Primary record

1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4,9-dihydroxy-, (4S)-; 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4,9-dihydroxy-, (S)-; Camptothecine, 10-hydroxy- (8CI); (+)-10-Hydroxycamptothecin; (S)-10-Hydroxycamptothecin; 10-Hydroxycamptothecin; 10-Hydroxycamptothecine; ChEMBL 273862; Hydroxycamptothecin; NSC 107124; (S)-4-ethyl-4,9-dihydroxy-1H-pyrano[3'4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; Topotecan related; SKF-S-104961; Irinotecan Related Compound A; Irinotecan Hydrochloride Trihydrate Impurity B; Irinotecan Impurity B

库存
3,661 克
纯度
98.7 %
CAS
19685-09-7

化合物标识与属性

CAS
19685-09-7
PubChem CID
97226
SMILES
CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=CC5=C4)O)O
Canonical SMILES
CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3cc(O)ccc3nc2-1

名称与同义词

  • 10-Hydroxycamptothecin
  • (S)-10-Hydroxycamptothecin
  • Hydroxycamptothecin
  • 19685-09-7
  • 10-hydroxycamptothecine
  • Hydroxycamptothecine
  • 10-Hydroxy camptothecin
  • Camptothecin, hydroxy-
  • Hydroxy camptothecine
  • HCPT
  • HCPT cpd
  • hydroxycamptothecinum
  • 10-Hydroxy-Camptothecin
  • 10-HCPT
  • Hydroxycamptothecin-10
  • 10-Hydroxy-CPT
  • Camptothecine, 10-hydroxy-
  • Irinotecan related compound a
  • Camptothecin, 10-hydroxy-
  • 10hydroxy camptothecin
  • 10-Hydroxycamptochecin
  • Spectrum_001639
  • 10-Hydroxycamp-totecin
  • RefChem:77529
  • SpecPlus_000763
  • 10 hydroxy Camptothecin
  • Spectrum2_001660
  • Spectrum3_001621
  • Spectrum4_001815
  • Spectrum5_000549
  • Trifluoromethylhypofluorite
  • ethyl(dihydroxy)[?]dione
  • Irinotecan EP Impurity B
  • 7-ethy hydroxycamptothecin
  • MFCD02093100
  • D07ILP
  • UNII-9Z01632KRV
  • AC1L3Y2F
  • AC1Q6AQ3
  • CHEMBL273862
  • 9Z01632KRV
  • C20H16N2O5
  • (20S)-10-Hydroxycamptothecin
  • SCHEMBL25875
  • BSPBio_003281
  • KBioGR_002454
  • KBioSS_002119
  • (S)-10-Hydroxycamptothecin hydrate
  • CAMPTOTHECIN, 10-HYDROXY
  • DivK1c_006859
  • NSC 107124
  • NSC-107124
  • SPECTRUM1504123
  • SPBio_001819
  • (4S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • HAWSQZCWOQZXHI-FQEVSTJZSA-N
  • NSC107124
  • orb1305050
  • SCHEMBL29350707
  • (S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • CHEBI:81395
  • CTK8B3047
  • ERK5-7I05
  • HY-N0095R
  • KBio1_001803
  • KBio2_002119
  • KBio2_004687
  • KBio2_007255
  • KBio3_002501
  • Camptothecin 10-Hydroxy Impurity
  • DTXSID00941444
  • DTXSID90987018
  • EX-A988
  • ZNTSSYJZVXCQGE-FQEVSTJZSA-N
  • KST-1A7243
  • 10-Hydroxycamptothecin, food grade
  • AOB33756
  • BCP01385
  • CID97226
  • EBD37036
  • HY-N0095
  • ZINC3979155
  • (+)-10-HYDROXYCAMPTOTHECIN
  • 2136AH
  • ANW-41680
  • AR-1A6082
  • BDBM50008922
  • CCG-38770
  • CH-068
  • CH0082
  • CID:97226
  • EBC-17074
  • MSK157282
  • s2423
  • s3898
  • (+)-(S)-10-HYDROXYCAMPTOTHECIN
  • 64439-81-2
  • AKOS015919293
  • AC-5502
  • ACN-035239
  • AN-1351
  • BCP9000058
  • CS-5193
  • CS-O-06296
  • DB12385
  • RL02475
  • (S)-10-Hydroxycamptothecin (Standard)
  • C20-H16-N2-O5.H2-O
  • 10-HYDROXYCAMPTOTHECIN [WHO-DD]
  • NCGC00095986-01
  • NCGC00095986-02
  • NCGC00095986-03
  • NCGC00095986-04
  • NCGC00178165-01
  • AC-13221
  • AJ-47579
  • AK-33939
  • AN-38748
  • AS-13196
  • BR-33939
  • H577
  • NCI60_000173
  • SC-19239
  • SID:53787862
  • SID:76715604
  • SY010687
  • AB0013128
  • J258.662B
  • LS-127397
  • TL8001609
  • TR-009134
  • Camptothecin, 10-Hydroxy-, Camptotheca acuminata
  • FT-0607192
  • FT-0689364
  • H1463
  • N2591
  • NS00018317
  • ST24032108
  • J3.021.724A
  • 10-hydroxycamptothecin;10-hydroxy camptothecin
  • 85H097
  • A11997
  • A25382
  • C17939
  • IRINOTECAN RELATED COMPOUND A [USP-RS]
  • M-1114
  • (S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4'
  • C028098
  • C527042
  • EN300-19810684
  • F787618
  • SR-05000002620
  • SR-05000002620-1
  • 50P550528
  • BRD-K63784565-001-02-1
  • BRD-K63784565-001-03-9
  • BRD-K63784565-001-05-4
  • BRD-K63784565-001-06-2
  • Q27155328
  • 67656-30-8
  • Z3093896188
  • (4s)-4-ethyl-4,9-dihydroxy-1h-pyrano[3',4':6,7]indolizino[1,2-b]chinolin-3,14(4h,12h)-dion
  • 50P550528001
  • B2703-086753
  • Irinotecan EP Impurity B; Camptothecin 10-Hydroxy Impurity
  • (19S)-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
  • (S)-4-ethyl-4,9-dihydroxy-1,12-dihydro-14H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione
  • 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4,9-dihydroxy-, hydrate, (S)-
  • (20S)-4-Ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione
  • (S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione ((S)-10-Hydroxycamptothecin)
  • 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione-,4-ethyl-4,9-dihydroxy-, (S)-
  • 6628-69-9
  • 10-Hydroxycamptothecin, 98%, from Taxus chinensis (Pilg.) Rehder - 10MG 10mg
  • 4-Ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione
  • (+/-)-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLINE-3,14(4H,12H)-DIONE
  • (19S)-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo(11.8.0.02,11.04,9.015,20)henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
  • (19S)-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
  • (4S)-4,9-Dihydroxy-4-ethyl-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • (4S)-4,9-Dihydroxy-4-ethyl-3,4,12,14-tetrahydro-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14-dione
  • (4S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • (4S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; 10-Hydroxycamptothecin; 10-Hydroxycamptothecine; NSC 107124
  • (4S)-4-Ethyl-4beta,9-dihydroxy-3,4,12,14-tetrahydro-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14-dione
  • (4S)-4alpha-Ethyl-4,9-dihydroxy-3,4,12,14-tetrahydro-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14-dione
  • (4S)-4alpha-Ethyl-4beta,9-dihydroxy-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • (4S)-9-Hydroxy-4-hydroxy-4-ethyl-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • (alphaS)-alpha,2-Dihydroxy-alpha-ethyl-8-(hydroxymethyl)-9-oxo-9,11-dihydroindolizino[1,2-b]quinoline-7-acetic acid 7,8-lactone
  • (S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3 inverted exclamation mark ,4 inverted exclamation mark :6,7]indolizino[1,2-b]quinoline-3,14-(4H,12H)-dione
  • (S)-4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14-(4H,12H)-dione
  • 130194-92-2
  • 1H-PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLINE-3,14(4H,12H)-DIONE, 4-ETHYL-4,9-DIHYDROXY-, (4S)-
  • 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4,9-dihydroxy-, (4S)-; 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4,9-dihydroxy-, (S)-; Camptothecine, 10-hydroxy- (8CI); (+)-10-Hydroxycamptothecin; (S)-10-Hydroxycamptothecin; 10-Hydroxycamptothecin; 10-Hydroxycamptothecine; ChEMBL 273862; Hydroxycamptothecin; NSC 107124; (S)-4-ethyl-4,9-dihydroxy-1H-pyrano[3'4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione; Topotecan related; SKF-S-104961; Irinotecan Related Compound A; Irinotecan Hydrochloride Trihydrate Impurity B; Irinotecan Impurity B
  • 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione-,4-ethyl-4,9-dihydroxy-, (S)-
  • 1H-Pyrano[3',7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione-,4-ethyl-4,9-dihydroxy-, (S)-
  • 4-Ethyl-4,10-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione
  • 4-Ethyl-4,10-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • 4-Ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione (10-hydroxycamptothecin)
  • 4-Ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • 613-598-9